An overview of the Novavax Nuvaxovid™ and Medicago Covifenz® COVID-19 vaccinesOrganization: Public Health Agency of Canada (PHAC)
May 10, 2022
Duration: 18 minutes
This webcast offers health care providers an overview of the clinical evidence and National Advisory Committee on Immunization (NACI) recommendations for the use of Novavax Nuvaxovid™ and Medicago Covifenz® COVID-19 vaccines recently authorized in Canada.
Iman Abdishukri, RN - Public Health Agency of Canada
Complete Post Webcast Evaluation Survey: Click Here
Slides Available: Click Here
Product Type: Webcast
Audience: Health Care Professional
Resource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.